Bifidobacterium infantis can reduce the ability of systemic pro-inflammatory biomarkers and make INF-α decreased in chronic fatigue syndrome and psoriasis, and IL-6 decreased in ulcerative colitis and chronic fatigue syndrome (Groeger et al., 2013). This evidence concerns the gene IFNA17 and myalgic encephalomeyelitis/chronic fatigue syndrome.